Data mining and network pharmacology: prescription formulation rules and mechanism of traditional Chinese medicine for gout
JIANG Ping,WU Xinyao,DU Xingchen,ZHANG Yuanyuan,JIANG Ting,WANG Rongsheng,ZHU Qi,GUAN Fengyuan,LU Ying,SU Xiao,LI Hongbin,JIANG Hongyang,FANG Yongfei,ZHAO Hengli,PENG Jiangyun,GAO Mingli,SU Li,HE Fang,TAO Qingwen,HU Chunrong,LI Peng,LI Zeguang,ZHU Yuelan,GU Ying,JIANG Quan,ZHANG Ming,ZHANG Jianyong,XUE Yu,HE Dongyi
DOI: https://doi.org/10.16305/j.1007-1334.2023.2210008
2023-01-01
Abstract:Objective To analyze the prescription formulation rules of traditional Chinese medicine（TCM） and the molecular mechanism of relevant traditional Chinese herbal medicines（TCHMs） for the treatment of gout based on a data mining analysis and a network pharmacology approach.Methods With Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine as the initiator, consultation data of gout patients from 22 hospitals in 10 provinces（including autonomous regions and municipalities directly under the central government） across China were retrospectively analyzed to extract information on the names, tastes, properties, meridian tropism and effects of traditional Chinese herbal medicines（TCHMs）. Microsoft Excel 2019 was used for analysis of frequency and relative frequency, and SPSS Modeler 18.0 and SPSS Statistics 20.0 were used for association rules and systematic cluster analysis of high-frequency TCHMs. Based on the data mining results, the active components of TCHMs were obtained from databases including Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform（TCMSP）, Integrative Pharmacology-based Research Platform of Traditional Chinese Medicine（TCMIP）, Encyclopedia of Traditional Chinese Medicine（ETCM） and Herb, and they were filtered thereafter. The Canonical SMILES format of active components of TCHMs was obtained from PubChem and then imported into SwissTargetPrediction database to predict the target genes of the active components. The disease genes associated with gout were retrieved from databases including GeneCards, Therapeutic Target Database（TTD）, DisGeNET data, Online Mendelian Inheritance in Man（OMIM） and Pharmacogenetics and Pharmacogenomics Knowledge Base（PharmGKB）, and then intersect analysis was conducted to obtain common genes.Cytoscape 3.7.2 was used to obtain the core genes for the treatment of gout with TCHMs, perform pathway analysis and association analysis, and construct a “herb-component-gene-signaling pathway” network. Results（1）In this study, clinical data of 2,688 gout patients were collected, and 659 prescriptions involving 266 TCHMs were obtained, including 36 high-frequency TCHMs [Tufuling（Smilacis Glabrae Rhizoma）, Yiyiren（Coicis Semen）, Chuanniuxi（Cyathulae Radix）, Cangzhu（Atractylodis Rhizoma）, Huangbo（Phellodendri Chinensis Cortex）, Qinjiao（Gentianae Macrophyllae Radix）, Duhuo（Angelicae Pubescentis Radix）, and Weilingxian（Clematis Radix et Rhizoma）, etc.].（2）TCHMs for the treatment of gout were mainly sweet, bitter and pungent in taste, and cold, neutral and warm in nature, manifesting their therapeutic effects on the liver, lung, stomach, spleen and kidney meridians in preference, with the effects of clearing heat, tonifying deficiency, promoting diuresis and defusing dampness, activating blood circulation and resolving stasis and dispelling wind-dampness.（3） The association rules showed that the medicinal combinations commonly used in the clinical treatment of gout were Tufuling（Smilacis Glabrae Rhizoma）-Yiyiren（Coicis Semen） and Cangzhu（Atractylodis Rhizoma）-Huangbo（Phellodendri Chinensis Cortex）, etc. According to systematic cluster analysis, 6 new medicinal combinations were formed and the core prescription for gout might include Dilong（Pheretima）, Biejia（Trionycis Carapax）, Qinjiao（Gentianae Macrophyllae Radix）, Chuanniuxi（Cyathulae Radix）, Yiyiren（Coicis Semen） and Tufuling（Smilacis Glabrae Rhizoma）.（4）The results of the network pharmacological analysis showed that baicalin, wogonin, quercetin, and kaempferol might be the key components for the treatment of gout, which could act on genes such as tumor necrosis factor（TNF）, serine/threonine kinase 1（AKT1）, interleukin-6（IL-6） and sarcoma（SRC）, etc., and these components exerted their therapeutic effects through regulating apoptosis, transforming growth factor-β（TGF-β）, and other multiple pathways. Conclusions TCM treatment of gout follows the principle of treating both the manifestations and the root cause. The main method is clearing heat and tonifying deficiency, which is supported by promoting diuresis and defusing dampness, as well as activating blood circulation and resolving stasis. The treatment of gout with TCHMs is mainly achieved by acting on key genes such as TNF, AKT1, IL-6 and SRC and by regulating apoptosis, necroptosis, TGF-β and other signaling pathways.